Millennium Management’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.9M | Sell |
243,876
-24,862
| -9% | -$398K | ﹤0.01% | 2239 |
|
|
2025
Q1 | $4.09M | Sell |
268,738
-95,920
| -26% | -$1.46M | ﹤0.01% | 2100 |
|
|
2024
Q4 | $7.4M | Sell |
364,658
-144,757
| -28% | -$2.94M | ﹤0.01% | 1767 |
|
|
2024
Q3 | $13.1M | Buy |
+509,415
| New | +$13.1M | 0.01% | 1377 |
|
|
2024
Q2 | – | Sell |
-137,587
| Closed | -$3.15M | – | 4502 |
|
|
2024
Q1 | $3.15M | Buy |
137,587
+117,201
| +575% | +$2.68M | ﹤0.01% | 2303 |
|
|
2023
Q4 | $534K | Buy |
20,386
+4,621
| +29% | +$121K | ﹤0.01% | 3141 |
|
|
2023
Q3 | $443K | Sell |
15,765
-16,443
| -51% | -$462K | ﹤0.01% | 3315 |
|
|
2023
Q2 | $979K | Buy |
+32,208
| New | +$979K | ﹤0.01% | 2934 |
|
|
2022
Q4 | – | Sell |
-5,323
| Closed | -$140K | – | 5226 |
|
|
2022
Q3 | $140K | Buy |
+5,323
| New | +$140K | ﹤0.01% | 4590 |
|